Mark Berjanskii

Dr. Mark Berjanskii


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2025 in Metabolomics
Verified
Journal Article
Open access
PDF file
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
HZHelena U. Zacharias
Helena U. Zacharias
MAMarcos Rodrigo Alborghetti
Marcos Rodrigo Alborghetti
G. A. Nagana GowdaG. A. Nagana Gowda
G. A. Nagana Gowda
DRDaniel Raftery
Daniel Raftery
David Scott WishartDavid Scott Wishart
David Scott Wishart
Background Metabolic profiling of blood metabolites, particularly in plasma and serum, is vital for studying human diseases, human conditions, drug interventions and toxicology. The clinical significance of blood arises from its close ties to all human cells and facile accessibility. However, patient-specific variables such as age, sex, diet, lifestyle and health status, along with pre-analytical conditions (sample handling, storage, etc.), can significantly affect metabolomic measurements in whole blood, plasma, or serum studies. These factors, referred to as confounders, must be mitigated to reveal genuine metabolic changes due to illness or intervention onset. Review objective This review aims to aid metabolomics researchers in collecting reliable, standardized datasets for NMR-based blood (whole/serum/plasma) metabolomics. The goal is to reduce the impact of confounding factors and enhance inter-laboratory comparability, enabling more meaningful outcomes in metabolomics studies. Key concepts This review outlines the main factors affecting blood metabolite levels and offers practical suggestions for what to measure and expect, how to mitigate confounding factors, how to properly prepare, handle and store blood, plasma and serum biosamples and how to report data in targeted NMR-based metabolomics studies of blood, plasma and serum.

30 November 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
AFAidin Foroutan
Aidin Foroutan
CFCarolyn Fitzsimmons
Carolyn Fitzsimmons
RMRupasri Mandal
Rupasri Mandal
MBMark Berjanskii
Mark Berjanskii
David Scott WishartDavid Scott Wishart
David Scott Wishart
Residual feed intake (RFI) is a feed efficiency measure commonly used in the livestock industry to identify animals that efficiently/inefficiently convert feed into meat or body mass. Selection for low-residual feed intake (LRFI), or feed efficient animals, is gaining popularity among beef producers due to the fact that LRFI cattle eat less and produce less methane per unit weight gain. RFI is a difficult and time-consuming measure to perform, and therefore a simple blood test that could distinguish high-RFI (HRFI) from LRFI animals (early on) would potentially benefit beef farmers in terms of optimizing production or selecting which animals to cull or breed. Using three different metabolomics platforms (nuclear magnetic resonance (NMR) spectrometry, liquid chromatography-tandem mass spectrometry (LC-MS/MS), and inductively coupled plasma mass spectrometry (ICP-MS)) we successfully identified serum biomarkers for RFI that could potentially be translated to an RFI blood test. One set of predictive RFI biomarkers included formate and leucine (best for NMR), and another set included C4 (butyrylcarnitine) and LysoPC(28:0) (best for LC-MS/MS). These serum biomarkers have high sensitivity and specificity (AUROC > 0.85), for distinguishing HRFI from LRFI animals. These results suggest that serum metabolites could be used to inexpensively predict and categorize bovine RFI values. Further validation using a larger, more diverse cohort of cattle is required to confirm these findings.

19 May 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
TSTanvir Sajed
Tanvir Sajed
ZSZinat Sayeeda
Zinat Sayeeda
BLBrian L. Lee
Brian L. Lee
MBMark Berjanskii
Mark Berjanskii
FWFei Wang
Fei Wang
David Scott WishartDavid Scott Wishart
David Scott Wishart
NMR is widely considered the gold standard for organic compound structure determination. As such, NMR is routinely used in organic compound identification, drug metabolite characterization, natural product discovery, and the deconvolution of metabolite mixtures in biofluids (metabolomics and exposomics). In many cases, compound identification by NMR is achieved by matching measured NMR spectra to experimentally collected NMR spectral reference libraries. Unfortunately, the number of available experimental NMR reference spectra, especially for metabolomics, medical diagnostics, or drug-related studies, is quite small. This experimental gap could be filled by predicting NMR chemical shifts for known compounds using computational methods such as machine learning (ML). Here, we describe how a deep learning algorithm that is trained on a high-quality, “solvent-aware” experimental dataset can be used to predict 1H chemical shifts more accurately than any other known method. The new program, called PROSPRE (PROton Shift PREdictor) can accurately (mean absolute error of 600,000 molecules in many popular metabolomic, drug, and natural product databases.

22 October 2022
Verified
Book Chapter
Closed access
PDF file
David Scott WishartDavid Scott Wishart
David Scott Wishart
MRManoj Rout
Manoj Rout
BLBrian L. Lee
Brian L. Lee
MBMark Berjanskii
Mark Berjanskii
MLMarcia LeVatte
Marcia LeVatte
MLMatthias Lipfert
Matthias Lipfert